Central Serous Chorioretinopathy (CSC)

Central serous chorioretinopathy is a retinal condition in which fluid accumulates under the retina at the macula, causing a localised detachment that distorts and blurs central vision. It often affects working-age adults, more commonly men, and is associated with stress and with corticosteroid use.

How it presents

People with CSC typically notice blurred or dim central vision, distortion of straight lines, a relative blind spot, or changes in how they perceive size and colour in the affected eye. Many acute cases resolve on their own as the fluid reabsorbs. When the condition persists or recurs, it is described as chronic CSC (cCSC), and the prolonged presence of fluid can threaten lasting damage to the retinal cells.

How it is managed

Management depends on whether the condition is acute or chronic. Acute CSC is often observed, with attention to modifiable factors such as corticosteroid exposure and stress. Chronic CSC may be treated with approaches directed at the choroid and retinal pigment epithelium, decided by a retinal specialist.

Emerging interest in photobiomodulation

Because photobiomodulation acts on retinal cell metabolism, mitochondrial function and the choroidal circulation, mechanisms relevant to the choroid-driven fluid problem in CSC, there is early-stage interest in its role in managing chronic CSC. This is an emerging area rather than an established treatment, and any use would be within cleared indications and under the direction of a retinal specialist. The broader posterior-segment rationale is described under dry AMD and how photobiomodulation works.

Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.